Cannae (NYSE:CNNE – Get Free Report) is anticipated to post its Q4 2025 results after the market closes on Monday, February 23rd. Analysts expect Cannae to post earnings of ($0.36) per share and revenue of $102.70 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Monday, February 23, 2026 at 5:00 PM ET.
Cannae Trading Down 0.1%
CNNE opened at $13.33 on Monday. The stock has a market cap of $656.66 million, a price-to-earnings ratio of -1.72 and a beta of 1.09. The stock’s 50 day moving average price is $15.50 and its 200-day moving average price is $17.18. Cannae has a one year low of $13.28 and a one year high of $21.96. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.03 and a current ratio of 2.03.
Institutional Investors Weigh In On Cannae
A number of institutional investors and hedge funds have recently bought and sold shares of CNNE. Quantbot Technologies LP purchased a new stake in shares of Cannae in the 2nd quarter worth $62,000. Kelleher Financial Advisors bought a new stake in shares of Cannae in the third quarter valued at about $73,000. Bank of Montreal Can purchased a new stake in Cannae in the fourth quarter worth about $179,000. Cerity Partners LLC bought a new position in Cannae during the 4th quarter worth about $183,000. Finally, Envestnet Asset Management Inc. increased its position in Cannae by 27.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 12,614 shares of the company’s stock valued at $231,000 after purchasing an additional 2,716 shares during the period. 88.12% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on Cannae
About Cannae
Cannae Holdings, Inc (NYSE: CNNE) is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae’s investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.
Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.
See Also
- Five stocks we like better than Cannae
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- America’s 1776 happening again
- Trump & Musk’s Secret Bet on Silver — Exposed
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Cannae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannae and related companies with MarketBeat.com's FREE daily email newsletter.
